Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BGMS
2576
Bio Green Med Solution Inc
BGMS
$5.62M
| $983K | ﹤0.01% |
2
+1
| +100% | +$399K |
2014 Q4
7 quarters
|
|
|
HMNF
2577
DELISTED
HMN Financial Inc
HMNF
| $982K | ﹤0.01% |
69,400
+1,900
| +3% | +$26.7K |
2013 Q2
13 quarters
|
|
|
WPT
2578
DELISTED
World Point Terminals, LP
WPT
| $982K | ﹤0.01% |
65,493
+14,690
| +29% | +$228K |
2016 Q2
1 quarter
|
|
|
SIOX
2579
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $977K | ﹤0.01% |
+8,725
| New | +$1.05M |
2016 Q3
0 quarters
|
|
|
MTL
2580
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $976K | ﹤0.01% |
+341,211
| New | +$690K |
2016 Q3
0 quarters
|
|
2581
LXP Industrial Trust
LXP
$3.6B
| $974K | ﹤0.01% |
18,916
+2,680
| +17% | +$141K |
2013 Q2
13 quarters
|
|
2582
Virco
VIRC
$102M
| $974K | ﹤0.01% |
232,000
+47,100
| +25% | +$206K |
2013 Q2
13 quarters
|
|
2583
Varonis Systems
VRNS
$5.76B
| $972K | ﹤0.01% |
96,900
-137,250
| -59% | -$1.26M |
2016 Q1
2 quarters
|
|
2584
Kamada
KMDA
$466M
| $967K | ﹤0.01% |
188,500
+15,700
| +9% | +$69.1K |
2013 Q4
11 quarters
|
|
2585
UnitedHealth
UNH
$340B
| $966K | ﹤0.01% |
+6,900
| New | +$966K |
2016 Q3
0 quarters
|
|
2586
Ameresco
AMRC
$1.13B
| $963K | ﹤0.01% |
183,000
+24,800
| +16% | +$123K |
2015 Q1
6 quarters
|
|
|
CBIO
2587
Crescent Biopharma
CBIO
$554M
| $959K | ﹤0.01% |
1,341
+195
| +17% | +$149K |
2015 Q1
6 quarters
|
|
|
TLN
2588
DELISTED
Talen Energy Corporation
TLN
| $958K | ﹤0.01% |
69,200
+19,900
| +40% | +$273K |
2015 Q3
4 quarters
|
|
|
ONC
2589
BeOne Medicines Ltd
ONC
$40.1B
| $952K | ﹤0.01% |
+30,900
| New | +$897K |
2016 Q3
0 quarters
|
|
|
UTEK
2590
DELISTED
Ultratech Inc.
UTEK
| $952K | ﹤0.01% |
41,256
+32,056
| +348% | +$779K |
2015 Q4
3 quarters
|
|
2591
MBIA
MBI
$231M
| $950K | ﹤0.01% |
+122,000
| New | +$960K |
2016 Q3
0 quarters
|
|
|
WMAR
2592
DELISTED
West Marine Inc
WMAR
| $949K | ﹤0.01% |
114,800
-3,800
| -3% | -$34.4K |
2013 Q2
13 quarters
|
|
|
RBS.PRF.CL
2593
DELISTED
Royal Bk Of Scotland Gp
RBS.PRF.CL
| $949K | ﹤0.01% |
36,600
+13,200
| +56% | +$344K |
2013 Q2
13 quarters
|
|
2594
Scully Royalty
SRL
$77.7M
| $943K | ﹤0.01% |
92,043
+9,643
| +12% | +$106K |
2013 Q2
13 quarters
|
|
|
ONVI
2595
DELISTED
Onvia, Inc.
ONVI
| $942K | ﹤0.01% |
191,800
+500
| +0.3% | +$2.1K |
2013 Q2
13 quarters
|
|
2596
Kopin
KOPN
$806M
| $937K | ﹤0.01% |
430,000
-104,600
| -20% | -$234K |
2015 Q1
6 quarters
|
|
2597
Lincoln Educational Services
LINC
$745M
| $936K | ﹤0.01% |
425,600
+31,700
| +8% | +$61.1K |
2014 Q4
7 quarters
|
|
2598
Upland Software
UPLD
$10.6M
| $936K | ﹤0.01% |
10,620
+1,040
| +11% | +$87.2K |
2015 Q2
5 quarters
|
|
2599
Zedge
ZDGE
$46M
| $934K | ﹤0.01% |
273,194
-95,200
| -26% | -$405K |
2016 Q2
1 quarter
|
|
|
SAEX
2600
DELISTED
SAExploration Holdings, Inc.
SAEX
| $934K | ﹤0.01% |
5,681
+5,671
| +56,710% | +$1.77M |
2015 Q4
3 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.